Author Correction: Ligand-based drug design against Herpes Simplex Virus-1 capsid protein by modification of limonene through in silico approaches
Md. Rezaul Islam, Md. Shafiqul Islam Sovon, Ummy Amena, Miadur Rahman, Md. Eram Hosen, Ajoy Kumer, Mohammed Bourhia, Yousef A. Bin Jardan, Samir Ibenmoussa, Gezahign Fentahun Wondmie
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMonoclonal and Polyclonal Antibodies Research · HIV/AIDS drug development and treatment · Herpesvirus Infections and Treatments
Correction to: Scientific Reports 10.1038/s41598-024-59577-4, published online 29 April 2024
In the original version of this Article, Md. Rezaul Islam, Md. Shafiqul Islam Sovon, Ummy Amena, Miadur Rahman, Md. Eram Hosen and Ajoy Kumer were incorrectly affiliated with ‘Department of Biology, Bahir Dar University, P.O. Box 79, Bahir Dar, Ethiopia’.
The original Article has been corrected.